-
Biodegradable Polymer-Mediated sh/siRNA Delivery for Cancer Studies
Discovery of RNA interference (RNAi)-mediated specific gene silencing has raised
2025-07-15 42 -
Bioinformatic Analysis of Toll-Like Receptor Sequences and Structures
Continual advancements in computing power and sophistication, coupled with rapid
2025-07-15 42 -
Bioinformatic Approaches to siRNA Selection and Optimization
RNA interference mediated by short interfering RNA (siRNA) molecules represents
2025-07-15 55 -
Bioinformatics Identification of Antigenic Peptide: Predicting the Specificity of Major MHC Class I
Bioinformatics methods for immunology have become increasingly used over the las
2025-07-15 27 -
Bioluminescence Imaging to Evaluate Infections and Host Response In Vivo
The continued prospect of emerging pathogens and recent events including the acc
2025-07-15 32 -
Biomarkers Measuring the Activity of Toll-Like Receptor Ligands in Clinical Development Programs
Efforts to develop therapeutic approaches based on stimulation of Toll-like rece
2025-07-15 36 -
Bioreactor Production of scFv Fragments in Pichia pastoris
The pubmed search term “pastoris[Title] AND (express[Title] OR produced[Title] O
2025-07-15 38 -
Biosensor Analysis of Receptor-Ligand Interactions
Cytokines trigger growth factor responses through interaction with cell surface
2025-07-15 34 -
Biosynthetic Radiolabeling of Virus Glycoproteins for Immunoprecipitation and Electrophoretic Analys
There are many different approaches to a biochemical analysis of virus glycoprot
2025-07-15 31 -
Biotinylation of Antibodies
The high affinity and specificity of the avidin-biotin interaction permit divers
2025-07-15 22 -
Biotinylation of Antibody
Biotinylation of AntibodyAuthor: Nanci DonackiSource: Contributed by Nanci Donac
2025-07-15 29 -
Bispecific Antibody Derivatives Based on Full-Length IgG Formats
Monoclonal antibodies have emerged as an effective therapeutic modality, and num
2025-07-15 25 -
Bispecific Diabodies and Single-Chain Diabodies
Bispecific antibodies can be applied for a broad range of diagnostic and therpae
2025-07-15 25 -
Bispecific Monoclonal Antibodies for the Targeting of Type I Ribosome-Inactivating Proteins Against
Monoclonal antibodies (MAbs) recognizing tumor-associated antigens (TAA) have be
2025-07-15 26 -
Bivalent Diabodies
Single-chain Fv fragments exhibiting monovalent binding can be converted into bi
2025-07-15 25
